Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders

Author： Pathak Swati Roth Michael Verma Amit Steidl Ulrich

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.12, 2013-12, pp. : 1667-1675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Polymorphic N-Acetyltransferases on Non-Malignant Spontaneous Disorders and on Response to Drugs

Current Drug Metabolism, Vol. 9, Iss. 6, 2008-07 ,pp. : 532-537

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Chronic Non-Malignant Pain in the Elderly: Safety Considerations

By > Gibson Stephen J.

Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. : 457-474

Adis International

Access to resources Recommend Favorite

Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

By Heldin Carl-Henrik

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 69-79

Springer Publishing Company

Access to resources Recommend Favorite

Shoyogan improves dietary intake in severely anorexic patients with malignant or non‐malignant disease

Traditional & Kampo Medicine, Vol. 2, Iss. 2, 2015-09 ,pp. : 89-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacoeconomics of opioid therapy for chronic non-malignant pain

By Marcus Dawn A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite